Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vericel Corp (VCEL)  
$48.10 0.55 (1.13%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 52,373,000
Market Cap: 2.52(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $30.85 - $52.9
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  474
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 134,738 259,234 263,234 303,833
Total Sell Value $6,189,261 $10,761,080 $10,907,920 $12,010,179
Total People Sold 5 7 7 7
Total Sell Transactions 12 29 31 34
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 394
  Page 7 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2022-02-11 4 D $35.26 $27,327 D/D (775) 44,894     -
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2022-02-11 4 OE $0.00 $0 D/D 1,625 45,669     -
   Halpin Michael Chief Operating Officer   •       –      –    2022-02-11 4 D $35.26 $55,147 D/D (1,564) 8,683     -
   Halpin Michael Chief Operating Officer   •       –      –    2022-02-11 4 OE $0.00 $0 D/D 3,500 10,247     -
   Colangelo Dominick President and CEO   •       •      –    2022-02-06 4 D $33.91 $103,392 D/D (3,049) 147,121     -
   Colangelo Dominick President and CEO   •       •      –    2022-02-06 4 OE $0.00 $0 D/D 6,937 150,170     -
   Halpin Michael Chief Operating Officer   •       –      –    2022-02-06 4 D $33.91 $31,570 D/D (931) 6,747     -
   Halpin Michael Chief Operating Officer   •       –      –    2022-02-06 4 OE $0.00 $0 D/D 1,875 7,678     -
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2022-02-06 4 D $33.91 $10,512 D/D (310) 44,044     -
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2022-02-06 4 OE $0.00 $0 D/D 650 44,354     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       –      –    2021-12-31 4 D $39.30 $46,138 D/D (1,174) 11,613     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       –      –    2021-12-31 4 OE $0.00 $0 D/D 4,000 12,787     -
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2021-12-22 4 AS $40.08 $596,930 D/D (14,881) 43,547 -23%     
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2021-12-22 4 OE $10.95 $265,150 D/D 19,000 49,428     -
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2021-12-20 4 AS $40.00 $40,000 D/D (1,000) 39,428 -25%     
   Hopper Jonathan Mark Chief Medical Officer   •       –      –    2021-12-20 4 OE $10.95 $10,950 D/D 1,000 40,428     -
   Gilman Steven C   –       •      –    2021-10-27 4 AS $50.57 $252,870 D/D (5,000) 3,500 -28%     
   Gilman Steven C   –       •      –    2021-10-27 4 OE $3.74 $18,700 D/D 5,000 8,500     -
   Halpin Michael Chief Operating Officer   •       –      –    2021-10-26 4 AS $50.57 $505,689 D/D (10,000) 5,696 -26%     
   Halpin Michael Chief Operating Officer   •       –      –    2021-10-26 4 OE $2.65 $26,500 D/D 10,000 15,696     -
   Gilman Steven C   –       •      –    2021-09-30 4 AS $48.85 $244,255 D/D (5,000) 3,500 -27%     
   Gilman Steven C   –       •      –    2021-09-30 4 OE $3.74 $18,700 D/D 5,000 8,500     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       –      –    2021-09-30 4 D $48.80 $57,291 D/D (1,174) 8,720     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       –      –    2021-09-30 4 OE $0.00 $0 D/D 4,000 9,894     -
   Flynn Sean C. VP, General Counsel   •       –      –    2021-08-27 4 AS $55.11 $396,760 D/D (7,200) 2,419 -34%     
  394 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us